Calamos Advisors LLC Neuronetics, Inc. Transaction History

Calamos Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$6.22 - $15.54 $2.26 Million - $5.65 Million	-363,468 Closed	0 $0
Q2 2021 Jul 22, 2021	SELL	$10.15 - $17.25 $163,922 - $278,587	-16,150 Reduced 4.25%	363,468 $5.82 Million
Q1 2021 Apr 12, 2021	BUY	$10.6 - $21.27 $2.22 Million - $4.45 Million	208,985 Added 122.48%	379,618 $4.7 Million
Q4 2020 Jan 27, 2021	BUY	$4.95 - $11.45 $844,633 - $1.95 Million	170,633 New	170,633 $1.9 Million

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $30.8M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.